Systemic and local high mobility group box 1 concentrations during severe infection
Marieke A. D. van Zoelen(Long Island University), Tom van der Poll(Amsterdam Neuroscience), Marja A. Boermeester(Amsterdam University Medical Centers), Paul Bresser(OLVG), J. W. Olivier van Till(Astellas Pharma (Netherlands)), Michael W.T. Tanck(Amsterdam UMC Location University of Amsterdam), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Suzanne Q. van Veen(Sanquin), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Thierry Dugernier(Clinique Saint Pierre), Akitoshi Ishizaka(Keio University)
Cited by 88
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k